Chan Shin Mei, Weininger Gabe, Langford John, Jane-Wit Daniel, Dardik Alan
Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, United States.
Department of Surgery, Yale School of Medicine, New Haven, CT, United States.
Front Cardiovasc Med. 2021 Jul 21;8:715114. doi: 10.3389/fcvm.2021.715114. eCollection 2021.
Vascular disorders frequently have differing clinical presentations among women and men. Sex differences exist in vascular access for hemodialysis; women have reduced rates of arteriovenous fistula (AVF) maturation as well as fistula utilization compared with men. Inflammation is increasingly implicated in both clinical studies and animal models as a potent mechanism driving AVF maturation, especially in vessel dilation and wall thickening, that allows venous remodeling to the fistula environment to support hemodialysis. Sex differences have long been recognized in arterial remodeling and diseases, with men having increased cardiovascular events compared with pre-menopausal women. Many of these arterial diseases are driven by inflammation that is similar to the inflammation during AVF maturation. Improved understanding of sex differences in inflammation during vascular remodeling may suggest sex-specific vascular therapies to improve AVF success.
血管疾病在女性和男性中常常有不同的临床表现。血液透析的血管通路存在性别差异;与男性相比,女性动静脉内瘘(AVF)成熟率以及内瘘使用率较低。在临床研究和动物模型中,炎症越来越被认为是驱动AVF成熟的一种重要机制,尤其是在血管扩张和管壁增厚方面,这使得静脉能够重塑以适应内瘘环境从而支持血液透析。动脉重塑和疾病中的性别差异早已为人所知,与绝经前女性相比,男性心血管事件增多。许多这类动脉疾病是由与AVF成熟过程中相似的炎症驱动的。更好地了解血管重塑过程中炎症的性别差异可能会提示针对性别的血管治疗方法,以提高AVF的成功率。